Cystic fibrosis. A new disease pattern in adult medicine

被引:0
|
作者
Staab, D. [1 ]
Schwarz, C. [1 ]
机构
[1] Charite Univ Med Berlin, Klin Padiatrie Schwerpunkt Pneumol Immunol & Inte, Augustenburger Pl 1, D-13353 Berlin, Germany
来源
INTERNIST | 2018年 / 59卷 / 11期
关键词
Demography; Transition to adult care; Adolescence; Attitude to disease; Benchmarking; YOUNG-ADULTS; TRANSITION PROGRAMS; CARE; CENTERS; ADOLESCENTS; QUALITY; PATIENT; PARENTS;
D O I
10.1007/s00108-018-0498-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cystic fibrosis (CF) is an inherited incurable multi-organ disease. Improvement in treatment approaches over the last 20years have led to an increased life expectancy where the number of adult patients has doubled and will continue to increase exponentially. Due to the use of new substances which modulate the basic defect, a substantial improvement in the prognosis can be assumed but the existing healthcare structures in Germany do not meet these rising needs. With more than 50% of patients being adults, there are only very few internal medicine centers available. Only approximately one third of the patients are treated in adult health centers. Adolescence in particular is avery vulnerable phase of the disease, the risk of comorbidities is increased and adherence to the very laborious treatment recommendations is as a rule low. While in many other countries transition programs have been evaluated and implemented for more than 20years, in Germany there have only been rudimentary approaches to transition. Meanwhile investigations are available on the perceptions of adolescents with respect to coping with the disease and their treatment needs, including the perception of the time when the transition process should begin. Successful transition seems to be performed best in combined pediatric and adult centers, with the back-up of an experienced multidisciplinary team of healthcare providers
引用
收藏
页码:1138 / 1145
页数:8
相关论文
共 50 条
  • [1] Neuropsychological impairment in adult patients with cystic fibrosis.
    Epker, JT
    Maddrey, M
    [J]. ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 106 - 106
  • [2] Cystic fibrosis. Disease on the way to personalized therapy
    van Koningsbruggen-Rietschel, S.
    Rietschel, E.
    [J]. MONATSSCHRIFT KINDERHEILKUNDE, 2017, 165 (08) : 681 - 687
  • [3] ADULT CYSTIC-FIBROSIS - A NEW DISEASE
    MCCRAE, WM
    RAEBURN, JA
    [J]. SCOTTISH MEDICAL JOURNAL, 1985, 30 (01) : 59 - 59
  • [4] The liver in cystic fibrosis.
    Lacaille, F
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1997, 21 (8-9): : 607 - 618
  • [5] Pharmacogenetics and cystic fibrosis.
    不详
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (02): : 206 - 206
  • [6] Autoantibodies in Cystic Fibrosis.
    Low, T. B.
    Greene, C. M.
    O'Neill, S. J.
    McElvaney, N. G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [7] The Prevalence and Pattern Of Self Reported Joint Symptoms In Cystic Fibrosis.
    Orr, Carl
    McCarthy, Cormac
    Meurling, Johan
    O'Connell, Paul G.
    Gunaratnam, Cedric
    McElvaney, Noel G.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S875 - S875
  • [8] Sonographic features of the gallbladder and pancreas in adult patients with cystic fibrosis.
    Dietrich, CF
    Chichakli, M
    Bargon, J
    Caspary, WF
    Lembcke, B
    Zeuzem, S
    [J]. HEPATOLOGY, 1999, 30 (04) : 561A - 561A
  • [9] Challenges in pulmonary fibrosis. 3: Cystic lung disease
    Cosgrove, Gregory P.
    Frankel, Stephen K.
    Brown, Kevin K.
    [J]. THORAX, 2007, 62 (09) : 820 - 829
  • [10] Referral testing for cystic fibrosis.
    Pratt, VM
    Brown, T
    Kam-Morgan, L
    Eisenberg, M
    Heyward, GC
    Anderson, SM
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 251 - 251